We are conducting routine maintenance on portfolio manager. We'll be back up as soon as possible. Thanks for your patience.

10 Most Popular Funds in February 2017 (Taiwan Domiciled)

10 Most Searched for Taiwan Domiciled Funds by tw.morningstar.com users

Morningstar Editors 08 March, 2017 | 17:01
Facebook Twitter LinkedIn

1. Allianz Global Investors Target Income Fund B TWD

Morningstar Category: High Yield Bond - Other Hedged

Morningstar Rating (2017-02-28): Not Rated

2. Taishin High Dividend Yield Balanced Fund                           

Morningstar Category: TWD Moderate Allocation

Morningstar Rating (2017-02-28):Stars 5

3. ABITL Global High Yield Fund TA RMB

Morningstar Category: High Yield Bond - Other Hedged

Morningstar Rating (2017-02-28):Not Rated

4. ABITL Global High Yield Fund TA TWD

Morningstar Category: High Yield Bond - Other Hedged

Morningstar Rating (2017-02-28):Not Rated

5. Allianz Global Investors Taiwan Fund

Morningstar Category: Taiwan Small/Mid-Cap Equity

Morningstar Rating (2017-02-28):Stars 5

6. UBS (TW) Bond Fund - Asian High Yield - B

Morningstar Category: Asia High Yield Bond

Morningstar Rating (2017-01-31):Stars 3

7. Yuanta Global ETFs Stable Fund of Funds

Morningstar Category: Global Large-Cap Blend Equity

Morningstar Rating (2017-02-28):Stars 4

8. PineBridge Global Multi-Strategy High Yield Bond Fund B TWD

Morningstar Category: Global High Yield Bond

Morningstar Rating (2017-02-28):Stars 2

9. Allianz Global Investors Global Biotech Fund TWD

Morningstar Category: Sector Equity Biotechnology

Morningstar Rating (2017-02-28):Stars 3

10. Fuh Hwa Digital Economy Fund

Morningstar Category: Sector Equity Technology

Morningstar Rating (2017-02-28):Stars 4

 

 

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. 

 

 

Facebook Twitter LinkedIn

About Author

Morningstar Editors  -

© Copyright 2024 Morningstar Asia Ltd. All rights reserved.

Terms of Use        Privacy Policy         Disclosures